Latest Articles
FIGURE 1 MTFR2 is highly expressed in endometrial carcinoma and is a... - ResearchGate
FIGURE 1 MTFR2 is highly expressed in endometrial carcinoma and is a... ResearchGate
Published: March 14, 2025, 10:44 p.m.
Central Nervous System Metastases in Endometrial Carcinoma: A Case Series - Cureus
Central Nervous System Metastases in Endometrial Carcinoma: A Case Series Cureus
Published: March 12, 2025, 12:37 p.m.
Deciphering the tumor-immune interplay in endometrial carcinoma - MSN
Deciphering the tumor-immune interplay in endometrial carcinoma MSN
Published: March 11, 2025, 12:39 p.m.
Deciphering the tumor-immune interplay in endometrial carcinoma - News-Medical.Net
Deciphering the tumor-immune interplay in endometrial carcinoma News-Medical.Net
Published: March 11, 2025, 5:53 a.m.
Unveiling the Role of Tumor-Infiltrating Immune Cells in Endometrial Carcinoma - EIN News
Unveiling the Role of Tumor-Infiltrating Immune Cells in Endometrial Carcinoma EIN News
Published: March 10, 2025, 8:15 p.m.
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients - Nature.com
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients Nature.com
Published: March 6, 2025, 6:11 a.m.
Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings - Nature.com
Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings Nature.com
Published: Feb. 8, 2025, 11:59 a.m.
The qualitative and quantitative characteristics of serous endometrial carcinoma on MRI: applying a novel nomogram for predicting an aggressive histological type - Frontiers
The qualitative and quantitative characteristics of serous endometrial carcinoma on MRI: applying a novel nomogram for predicting an aggressive histological type Frontiers
Published: Feb. 3, 2025, 10:27 p.m.
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 - Frontiers
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 Frontiers
Published: Feb. 3, 2025, 2:27 p.m.
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma - Nature.com
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma Nature.com
Published: Jan. 17, 2025, 8:46 a.m.
Link copied to clipboard!